These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2216950)

  • 41. Effects of incretins on blood pressure: a promising therapy for type 2 diabetes mellitus with hypertension.
    Wang B; Ni Y; Zhong J; Sun F
    J Diabetes; 2012 Mar; 4(1):22-9. PubMed ID: 22040104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Captopril or conventional therapy in hypertensive type II diabetics. Three-year analysis.
    Lacourcière Y; Nadeau A; Poirier L; Tancrède G
    Hypertension; 1993 Jun; 21(6 Pt 1):786-94. PubMed ID: 8500859
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Arterial hypertension and diabetes mellitus].
    Kohlmann Júnior O
    AMB Rev Assoc Med Bras; 1987; 33(7-8):144-6. PubMed ID: 3502497
    [No Abstract]   [Full Text] [Related]  

  • 44. Hypotensive effect of the association atenolol-chlorthalidone in hypertensive diabetics.
    Gentile S; Coltorti M
    J Int Med Res; 1984; 12(5):281-5. PubMed ID: 6500167
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Indoramin in the hypertensive diabetic patient.
    Sood VP; Stannard M; Beastall G; Weir RJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S80-3. PubMed ID: 2423805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased microvascular permeability to plasma proteins in short- and long-term juvenile diabetics.
    Parving HH
    Diabetes; 1976; 25(2 SUPPL):884-9. PubMed ID: 9323
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antihypertensive and metabolic effects of long-term treatment with amosulalol in non-insulin dependent diabetics.
    Inoue Y; Yaga K; Nishimura M; Okafuji K; Fujii Y; Nagasaka Y; Tanaka M; Fujita N; Kaku K; Kaneko T
    Curr Med Res Opin; 1992; 12(9):564-71. PubMed ID: 1582238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of hypertension and albuminuria in a teaching hospital diabetes clinic.
    Ritchie CM; Beatty OL; McKnight JA; Hadden DR; Kennedy L; Atkinson AB
    Diabetes Res Clin Pract; 1995 Jan; 27(1):69-76. PubMed ID: 7781496
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nifedipine effectively lowers salt-induced high blood pressure in diabetic rats.
    Orie NN; Anyaegbu NO
    Gen Pharmacol; 1999 Apr; 32(4):471-4. PubMed ID: 10323488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pathophysiologic basis of arterial hypertension in diabetic patients].
    Czech A; Tatoń J
    Pol Tyg Lek; 1991 Jan 7-14; 46(1-3):3-6. PubMed ID: 1845663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of nifedipine on carbohydrate metabolism and serum lipoproteins in hypertensive patients with and without diabetes mellitus.
    Benaim ME; Macdonald G
    Eur Heart J; 1987 Nov; 8 Suppl K():15-20. PubMed ID: 3450519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased transvascular lipoprotein transport in diabetes: association with albuminuria and systolic hypertension.
    Jensen JS; Feldt-Rasmussen B; Borch-Johnsen K; Jensen KS; Nordestgaard BG
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4441-5. PubMed ID: 15899947
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pilot study of the effect of intravenous prostavasin therapy of inpatients with diabetes mellitus and IIb arterial occlusive disease].
    Rosak C; Hofmann U; König P; Nitsche GB
    Vasa Suppl; 1991; 33():339-40. PubMed ID: 1788748
    [No Abstract]   [Full Text] [Related]  

  • 54. Central role of sodium in hypertension in diabetic subjects.
    Weidmann P; Ferrari P
    Diabetes Care; 1991 Mar; 14(3):220-32. PubMed ID: 2044437
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Antihypertensive therapy with co-dergocrine mesilate/nifedipine in comparison with nifedipine in type II diabetes].
    Janka HU; Mehnert H
    Arzneimittelforschung; 1990 Sep; 40(9):980-3. PubMed ID: 2080948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blood pressure control in patients with type 2 diabetes and hypertension.
    González-Juanatey JR
    Diabetes Obes Metab; 2002 Mar; 4(2):81-8. PubMed ID: 11940104
    [No Abstract]   [Full Text] [Related]  

  • 57. [Blood pressure control].
    Katayama S
    Nihon Rinsho; 2010 Nov; 68 Suppl 9():136-9. PubMed ID: 21661149
    [No Abstract]   [Full Text] [Related]  

  • 58. Vascular dysfunction in diabetes.
    Wold LE; Lucchesi PA; Schaffer SW
    Vascul Pharmacol; 2012; 57(5-6):131-2. PubMed ID: 22846480
    [No Abstract]   [Full Text] [Related]  

  • 59. The prevalence of glaucoma and ocular hypertension in type 1 and 2 diabetes mellitus. An epidemiological study of diabetes mellitus on the island of Falster, Denmark.
    Nielsen NV
    Acta Ophthalmol (Copenh); 1983 Aug; 61(4):662-72. PubMed ID: 6637428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High circulating vascular endothelial growth factor (VEGF) is related to a better systolic function in diabetic hypertensive patients.
    Iacobellis G; Cipriani R; Gabriele A; Di Mario U; Morano S
    Cytokine; 2004 Jul; 27(1):25-30. PubMed ID: 15207248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.